FY2026 EPS Estimates for Nano-X Imaging Reduced by Analyst

Key Points

• Analysts at Cantor Fitzgerald have cut their FY2026 earnings estimates for Nano-X Imaging from ($0.29) to ($0.50) per share, indicating a more pessimistic outlook for the company.
• The company recently reported quarterly earnings of ($0.23) per share, missing consensus estimates, and has experienced a negative net margin of 468.29%.
• Institutional investors have increased their stakes in Nano-X, with hedge funds collectively owning 21.49% of the company's stock, signaling potential confidence among large investors.

Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) - Investment analysts at Cantor Fitzgerald reduced their FY2026 earnings per share (EPS) estimates for Nano-X Imaging in a note issued to investors on Wednesday, August 13th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will earn ($0.50) per share for the year, down from their previous forecast of ($0.29). The consensus estimate for Nano-X Imaging's current full-year earnings is ($0.92) per share.

Several other research firms have also commented on NNOX. LADENBURG THALM/SH SH upgraded Nano-X Imaging to a "strong-buy" rating in a research note on Monday, July 14th. D. Boral Capital cut their price objective on shares of Nano-X Imaging from $10.00 to $8.00 and set a "buy" rating on the stock in a report on Wednesday, August 13th. Finally, Alliance Global Partners upgraded shares of Nano-X Imaging to a "strong-buy" rating in a research note on Monday, August 11th.

Nano-X Imaging Trading Down 2.0%

Nano-X Imaging stock traded down $0.09 during trading hours on Friday, hitting $4.18. 298,871 shares of the stock traded hands, compared to its average volume of 1,768,362. The firm's 50-day moving average price is $5.02 and its two-hundred day moving average price is $5.38. Nano-X Imaging has a one year low of $3.75 and a one year high of $11.00. The company has a market cap of $241.23 million, a PE ratio of -4.64 and a beta of 1.95.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($0.23) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.08). Nano-X Imaging had a negative net margin of 468.29% and a negative return on equity of 32.09%. The business had revenue of $3.04 million for the quarter, compared to analysts' expectations of $3.20 million.

Institutional Investors Weigh In On Nano-X Imaging

Institutional investors and hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC raised its holdings in shares of Nano-X Imaging by 1,755.9% in the first quarter. GAMMA Investing LLC now owns 7,962 shares of the company's stock valued at $40,000 after buying an additional 7,533 shares during the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Nano-X Imaging during the second quarter worth about $57,000. Vident Advisory LLC acquired a new position in shares of Nano-X Imaging during the first quarter worth about $55,000. PharVision Advisers LLC acquired a new position in shares of Nano-X Imaging during the fourth quarter worth about $80,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Nano-X Imaging during the fourth quarter worth about $81,000. 21.49% of the stock is owned by hedge funds and other institutional investors.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.